The popularity of Ozempic for weight loss has fueled a cottage industry selling off-brand versions, taking advantage of a regulation allowing pharmacies to copy drugs in shortage.
. MinuteMD founder Joe Stiver said by email that the company “does not advertise any of its compounded products as FDA-approved.”
Asked about his criminal record, Stiver wrote: “I firmly believe you cannot judge a person’s character by a single incident; rather, you should evaluate someone on how they have overcome obstacles in their life.” He said he has worked to rehabilitate himself, and his companies donated medical equipment during the pandemic.
Even as compounding pharmacies have become an essential cog in the business of off-brand weight-loss medications, they also have become a source of some intrigue: The pharmacies are tight-lipped about where they obtain the raw semaglutide, which doesn’t come from Novo Nordisk, and the recipe could deviate from the drugmaker’s patented product.In March 2022, FDA inspectorsTailor Made for using semaglutide approved only for research, not for patient use.
日本 最新ニュース, 日本 見出し
Similar News:他のニュース ソースから収集した、これに似たニュース記事を読むこともできます。
Inside High School Sports: September 17, 2023NBC 5’s Pat Doney takes a look at the game of the week where the Anna Coyotes took on the Celina Bobcats. Also, this week’s MVP on Inside High School Sports.
続きを読む »
Shot fired inside Ball State University dormBall State University Police are investigating an accidental shot fired incident inside a dorm. Police say there is no threat to the public.
続きを読む »
Video shows 13-year-old girl brutally attacked by adult woman inside McDonald's in LomitaFamily members and community leaders are calling for justice after a 13-year-old was attacked and beaten inside a Lomita McDonald's, an incident that was captured in a now-viral video.
続きを読む »
Oakland woman killed by stray bullet while inside homePolice in Oakland said a stray bullet struck and killed a California mother of two Friday night while she was lying on the couch inside her home.
続きを読む »